Efficacy and Safety of iGlarLixi vs. IDegAsp in Non-Asian People with Type 2 Diabetes Inadequately Controlled with Basal Insulin-A Systemic Literature Review and Network Meta-analysis

被引：0
|
作者：
Home, Philip
Lauand, Felipe
Djaballah, Khier
Bourhis, Francois
Li, Xuan
Hafidh, Khadija
Mehta, Roopa
Faraoun, Khadra
Anaforoglu, Inan
Pourrahmat, Mir-Masoud
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1880-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1880-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis
    Home, Philip
    Blonde, Lawrence
    Kalra, Sanjay
    Ji, Linong
    Guyot, Patricia
    Brulle-Wohlhueter, Claire
    Murray, Erin
    Shah, Roshan
    Sayre, Toby
    Shaunik, Alka
    DIABETES OBESITY & METABOLISM, 2020, 22 (11): : 2179 - 2188
  • [32] Efficacy and Safety of Curcumin Supplement on Improvement of Insulin Resistance in People with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Zhang, Tianqing
    He, Qi
    Liu, Yao
    Chen, Zhenrong
    Hu, Hengjing
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [33] LIXISENATIDE, BASAL INSULIN AND PREMIXED INSULIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY ORAL ANTIDIABETIC DRUGS: NETWORK META-ANALYSIS AND COST-EFFECTIVENESS ANALYSIS
    Men, P.
    Qu, S.
    Li, C.
    Zhai, S.
    VALUE IN HEALTH, 2019, 22 : S150 - S150
  • [34] GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
    Grenet, Guillaume
    Ribault, Shams
    Giao Bao Nguyen
    Glais, Faustine
    Metge, Augustin
    Linet, Thomas
    Kassai-Koupai, Behrouz
    Cornu, Catherine
    Bejan-Angoulvant, Theodora
    Erpeldinger, Sylvie
    Boussageon, Remy
    Gouraud, Aurore
    Bonnet, Fabrice
    Cucherat, Michel
    Moulin, Philippe
    Gueyffier, Francois
    PLOS ONE, 2019, 14 (06):
  • [35] Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Xinxin
    Xiao, Wei
    Liang, Zhanpeng
    Li, Shixiang
    Tang, Qizhi
    MEDICINE, 2023, 102 (52) : E36308
  • [36] Efficacy and safety of metformin compared to insulin in gestational diabetes: a systemic review and meta-analysis of Chinese randomized controlled trials
    Li, Fang
    Liu, Ligang
    Hu, Yang
    Marx, Carrie McAdam
    Liu, Wei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (05) : 1102 - 1113
  • [37] Glucagon-like peptide-1 receptor agonists vs. insulin in inadequately controlled patients with type 2 diabetes. Is this meta-analysis miscalculated?
    Liatis, S.
    Makrilakis, K.
    DIABETES OBESITY & METABOLISM, 2014, 16 (03): : 284 - 284
  • [38] Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Alhmoud, Eman N.
    Saad, Mohamed Omar
    Omar, Nabil Elhadi
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [39] Efficacy and safety of twice daily vs. thrice daily injections of biphasic insulin aspart 30 in insulin naive patients with type 2 diabetes inadequately controlled with OADs
    Yang, Wenying
    Ji, Qiuhe
    Zhu, Dalong
    Yang, Jinkui
    Chen, Lulu
    Liu, Zhimin
    Yu, Demin
    Yan, Li
    DIABETES, 2007, 56 : A546 - A546
  • [40] A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF ANTI-DIABETES TREATMENTS FOR ADULTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON INSULIN AND ORAL ANTI-DIABETES DRUGS
    Orme, M.
    Mukherjee, J.
    Sternhufvud, C.
    Smith, N.
    Fenici, P.
    VALUE IN HEALTH, 2015, 18 (03) : A56 - A56
12345